{
  "document": "output/data/SherkowGugliuzza_PostSP_PostEEFormatting[70].docx",
  "started_at": "2025-08-09T00:41:41.319763",
  "footnote_range": "20-25",
  "used_gpt": true,
  "footnotes_processed": 6,
  "total_citations": 0,
  "successful_retrievals": 0,
  "failed_retrievals": 0,
  "pdf_files": [],
  "parsing_results": [
    {
      "footnote_number": 20,
      "original_text": "21 U.S.C. § 355(j)(2)(A)(i).",
      "citations_count": 0,
      "parsing_confidence": 0.0,
      "gpt_reasoning": "Parsing failed: Error code: 404 - {'error': {'message': 'The model `gpt-4` does not exist or you do not have access to it.', 'type': 'invalid_request_error', 'param': None, 'code': 'model_not_found'}}",
      "parsed_at": "2025-08-09T00:41:42.085867",
      "citations": []
    },
    {
      "footnote_number": 21,
      "original_text": "35 U.S.C. § 271(b);  see also   case s cited  supra  note  1 . In this circumstance, the doctors are what patent lawyers would call “direct infringers”—they are the ones actually  using  the brand’s p...",
      "citations_count": 0,
      "parsing_confidence": 0.0,
      "gpt_reasoning": "Parsing failed: Error code: 404 - {'error': {'message': 'The model `gpt-4` does not exist or you do not have access to it.', 'type': 'invalid_request_error', 'param': None, 'code': 'model_not_found'}}",
      "parsed_at": "2025-08-09T00:41:43.494741",
      "citations": []
    },
    {
      "footnote_number": 22,
      "original_text": "21 U.S.C. § 355(j)(2)(A)(viii).",
      "citations_count": 0,
      "parsing_confidence": 0.0,
      "gpt_reasoning": "Parsing failed: Error code: 404 - {'error': {'message': 'The model `gpt-4` does not exist or you do not have access to it.', 'type': 'invalid_request_error', 'param': None, 'code': 'model_not_found'}}",
      "parsed_at": "2025-08-09T00:41:44.389681",
      "citations": []
    },
    {
      "footnote_number": 23,
      "original_text": "  Caraco Pharm. Lab’ys, Ltd. v. Novo Nordisk A/S, 566 U.S. 399, 415 (2012) (“The statutory scheme . . . contemplates that one patented use will not foreclose marketing a generic drug for other unpaten...",
      "citations_count": 0,
      "parsing_confidence": 0.0,
      "gpt_reasoning": "Parsing failed: Error code: 404 - {'error': {'message': 'The model `gpt-4` does not exist or you do not have access to it.', 'type': 'invalid_request_error', 'param': None, 'code': 'model_not_found'}}",
      "parsed_at": "2025-08-09T00:41:44.500263",
      "citations": []
    },
    {
      "footnote_number": 24,
      "original_text": "In re  Barr Lab ’ ys, Inc., 930 F.2d 72, 76 (D.C. Cir. 1991) .",
      "citations_count": 0,
      "parsing_confidence": 0.0,
      "gpt_reasoning": "Parsing failed: Error code: 404 - {'error': {'message': 'The model `gpt-4` does not exist or you do not have access to it.', 'type': 'invalid_request_error', 'param': None, 'code': 'model_not_found'}}",
      "parsed_at": "2025-08-09T00:41:44.849044",
      "citations": []
    },
    {
      "footnote_number": 25,
      "original_text": " The Federal Circuit has exclusive jurisdiction over all appeals in patent cases nationwide. 28 U.S.C. § 1295(a)(1). ",
      "citations_count": 0,
      "parsing_confidence": 0.0,
      "gpt_reasoning": "Parsing failed: Error code: 404 - {'error': {'message': 'The model `gpt-4` does not exist or you do not have access to it.', 'type': 'invalid_request_error', 'param': None, 'code': 'model_not_found'}}",
      "parsed_at": "2025-08-09T00:41:45.653487",
      "citations": []
    }
  ],
  "retrieval_results": [],
  "completed_at": "2025-08-09T00:41:45.654042",
  "duration_seconds": 4.334279,
  "success_rate": 0.0
}